Cargando…
Evaluation of Novel Stereotactic Cannula for Stem Cell Transplantation against Central Nervous System Disease
Cell therapy for central nervous system (CNS) disorders is beginning to prove its safety and efficiency. Intraparenchymal transplantation can be an option for cell delivery; however, one concern regarding this method is that the transplantation cannula may cause additional brain injuries. These incl...
Autores principales: | Kawabori, Masahito, Tanimori, Aki, Kitta, Shinri, Shichinohe, Hideo, Houkin, Kiyohiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036105/ https://www.ncbi.nlm.nih.gov/pubmed/32104184 http://dx.doi.org/10.1155/2020/4085617 |
Ejemplares similares
-
Corrigendum to “Evaluation of Novel Stereotactic Cannula for Stem Cell Transplantation against Central Nervous System Disease”
por: Kawabori, Masahito, et al.
Publicado: (2021) -
Clinical Trials of Stem Cell Therapy for Cerebral Ischemic Stroke
por: Kawabori, Masahito, et al.
Publicado: (2020) -
Research on advanced intervention using novel bone marrOW stem cell (RAINBOW): a study protocol for a phase I, open-label, uncontrolled, dose-response trial of autologous bone marrow stromal cell transplantation in patients with acute ischemic stroke
por: Shichinohe, Hideo, et al.
Publicado: (2017) -
Clinical Trials of Stem Cell Treatment for Spinal Cord Injury
por: Yamazaki, Kazuyoshi, et al.
Publicado: (2020) -
Intracerebral Transplantation of Mesenchymal Stromal Cell Compounded with Recombinant Peptide Scaffold against Chronic Intracerebral Hemorrhage Model
por: Takamiya, Soichiro, et al.
Publicado: (2022)